Biomarin Pharmaceutical (BMRN) Interest & Investment Income (2017 - 2025)
Historic Interest & Investment Income for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Q3 2025 value amounting to $17.9 million.
- Biomarin Pharmaceutical's Interest & Investment Income fell 110.23% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.4 million, marking a year-over-year decrease of 248.91%. This contributed to the annual value of $74.9 million for FY2024, which is 2835.84% up from last year.
- Per Biomarin Pharmaceutical's latest filing, its Interest & Investment Income stood at $17.9 million for Q3 2025, which was down 110.23% from $18.8 million recorded in Q2 2025.
- Biomarin Pharmaceutical's Interest & Investment Income's 5-year high stood at $19.8 million during Q2 2024, with a 5-year trough of $1.7 million in Q4 2021.
- Moreover, its 5-year median value for Interest & Investment Income was $12.6 million (2023), whereas its average is $11.4 million.
- As far as peak fluctuations go, Biomarin Pharmaceutical's Interest & Investment Income tumbled by 5437.06% in 2021, and later surged by 55620.88% in 2023.
- Biomarin Pharmaceutical's Interest & Investment Income (Quarter) stood at $1.7 million in 2021, then skyrocketed by 399.14% to $8.7 million in 2022, then soared by 107.16% to $18.0 million in 2023, then fell by 2.02% to $17.7 million in 2024, then increased by 0.98% to $17.9 million in 2025.
- Its last three reported values are $17.9 million in Q3 2025, $18.8 million for Q2 2025, and $19.0 million during Q1 2025.